FINVX | GSIKX | FINVX / GSIKX | |
Total Expense Ratio | 0.01 | 0.84 | 1% |
Annual Report Gross Expense Ratio | 0.01 | 0.89 | 1% |
Fund Existence | 15 years | 18 years | - |
Gain YTD | 16.023 | 10.954 | 146% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.2B | 2.13B | 714% |
Annual Yield % from dividends | 4.22 | 2.99 | 141% |
Returns for 1 year | 16.85 | 16.17 | 104% |
Returns for 3 years | 54.96 | 46.57 | 118% |
Returns for 5 years | 95.49 | 71.40 | 134% |
Returns for 10 years | 80.24 | 86.31 | 93% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 9.14 | 0.08 | +0.84% |
Global X Genomics & Biotechnology ETF | |||
JULW | 34.98 | 0.11 | +0.33% |
AllianzIM US Large Cap Buffer20 Jul ETF | |||
ILCG | 84.52 | 0.21 | +0.25% |
iShares Morningstar Growth ETF | |||
SPAX | 20.35 | 0.01 | +0.05% |
Robinson Alternative Yld Pr-Mrgr SPACETF | |||
SKOR | 48.11 | -0.04 | -0.08% |
FlexShares Credit-Scored US Corp Bd ETF |